TABLE 2.
Patient no. | Sex | Age (yrs) | Group | Immune status/medical history | Onset of symptoms (days) | Result |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SV-PCR |
LV-PCR |
PCR, ocular sample |
GWC | WB | |||||||||
RE | B1 | RE | B1 | RE | B1 | ||||||||
1 | F | 70 | OT | Horton's disease (corticoid + immunosuppressive regimen) | 30 | + | − | + | − | + | + | ND | − |
2 | M | 45 | OT | HIV infected | 3 | − | − | − | + | + | + | 1 | − |
3 | F | 66 | OT | CREST syndrome | 90 | − | − | − | + | + | + | 1.1 | − |
4 | M | 35 | CTRL | HIV infected | 10 | − | − | + | − | − | − | 0.8 | − |
5 | M | 48 | CTRL | HIV infected (300 CD4+/mm3) | NA | − | − | + | − | − | − | NA | − |
6 | M | 48 | CTRL | Immunocompetent, retinal syphilis | 180 | + | − | ND | ND | − | − | NA | − |
7 | F | 56 | OT | HIV infected (21 CD4+/mm3) | 15 | + | − | − | − | + | − | 0.5 | − |
8 | F | 22 | OT | Immunocompetent | 14 | − | − | + | − | − | − | 333.4 | + |
9 | F | 51 | OT | HIV infected | 14 | − | − | + | + | + | − | 0.4 | − |
10 | F | 52 | OT | HIV infected (110 CD4+/mm3) | 10 | + | − | ND | ND | + | + | ||
11 | F | 76 | OT | Lupus (corticoid and immunosuppressive regimen) | 15 | + | − | + | − | + | + | 5.7 | − |
12 | M | 28 | OT | Immunocompetent | NA | − | − | − | + | − | − | 5.5 | + |
13 | F | 22 | OT | Immunocompetent | 7 | − | − | − | + | − | − | 1.2 | − |
14 | M | 61 | OT | Immunocompetent | 90 | − | − | − | + | + | + | 4.1 | + |
15 | M | 35 | OT | Immunocompetent | 6 | + | + | ND | ND | − | − |
F, female; M, male; OT, ocular toxoplasmosis; CTRL, control; SV-PCR, small-volume PCR; LV-PCR, large-volume PCR; +, positive test; −, negative test; GWC, Goldmann-Witmer coefficient; WB, Western blot; ND, not done; NA, not available.